While entangled photons hold incredible promise for quantum computing and communications, they have a major inherent disadvantage. After one use, they simply disappear. In a new study physicists ...

A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

Researchers have found that a newly developed diet inspired by the eating habits of non-industrialized societies can significantly reduce the risk of a number of chronic diseases -- and are to share ...

A team has identified a strain of bacteria that can break down and transform at least three types of PFAS, and, perhaps even more crucially, some of the toxic byproducts of the bond-breaking process.

A new national survey found that while many Americans use a device to monitor their heart, few share that data with their doctor.

Adults who have been diagnosed with attention deficit hyperactivity disorder (ADHD) may be living shorter lives than they should, finds a new study.

A new study has used a modelling approach to show that it is unlikely that plants would evolve to warn other plants of impending attack. Instead of using their communication networks to transmit ...

Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that encodes for ...

Perovskite solar cells are a flexible and sustainable alternative to conventional silicon-based solar cells. Researchers were able to find -- within only a few weeks -- new organic molecules that ...

Deeply hidden in Earth's mantle there are two huge 'islands' with the size of a continent. New research shows that these regions are not only hotter than the surrounding graveyard of cold sunken ...

The remains of the earliest dinosaurs may lie undiscovered in the Amazon and other equatorial regions of South America and Africa, suggests a new study.

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...